Magalie Haissaguerre

Dr. Magalie Haissaguerre


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2022 in Annales d'Endocrinologie
Verified
Journal Article
Closed access
ALAlexandre LUGAT
Alexandre LUGAT
HLHélène Lasolle
Hélène Lasolle
MFMaud François
Maud François
NBNesrine Benhenda
Nesrine Benhenda
LBLéopoldine Bricaire
Léopoldine Bricaire
MHMagalie Haissaguerre
Magalie Haissaguerre

21 October 2022 in Annales d'Endocrinologie
Verified
Journal Article
Closed access
CCChristine Do Cao
Christine Do Cao
MHMagalie Haissaguerre
Magalie Haissaguerre
CLCharlotte Lussey-Lepoutre
Charlotte Lussey-Lepoutre
GDGianluca Donatini
Gianluca Donatini
VRVéronique Raverot
Véronique Raverot
GRGilles Russ
Gilles Russ


1 October 2018 in Annales d'Endocrinologie
Verified
Journal Article
Closed access
MHMagalie Haissaguerre
Magalie Haissaguerre
SHS. Hescot
S. Hescot
JBJ. Bertherat
J. Bertherat
OCOlivier Chabre
Olivier Chabre

3 March 2023 in European Journal of Endocrinology
Verified
Journal Article
Closed access
PDF file
MHMagalie Haissaguerre
Magalie Haissaguerre
ELEstelle Louiset
Estelle Louiset
CJChristofer C Juhlin
Christofer C Juhlin
ASAdam Stenman
Adam Stenman
CLChristophe Laurent
Christophe Laurent
ATAntoine Tabarin
Antoine Tabarin
We report a unique case of a 44-year-old man with paraneoplastic hyperparathyroidism due to an oncocytic adrenocortical carcinoma (stage pT3N0R0M0, ENSAT 2 with a 4% Ki-67). Paraneoplastic hyperparathyroidism was associated with mild adrenocorticotropic hormone (ACTH)–independent hypercortisolism and increased estradiol secretion responsible for gynecomastia and hypogonadism. Biological investigations performed in blood samples from peripheral and adrenal veins revealed that the tumor secreted parathyroid hormone (PTH) and estradiol. Ectopic PTH secretion was confirmed by abnormally high expression of PTH mRNA and clusters of PTH immunoreactive cells in the tumor tissue. Double-immunochemistry studies and analysis of contiguous slides for the expression of PTH and steroidogenic markers (scavenger receptor class B type 1 [SRB1], 3β-hydroxysteroid dehydrogenase [3β-HSD], and aromatase) were performed. The results suggested the presence of two tumor cells subtypes with large cells with voluminous nuclei producing only PTH and that were distinct from steroid-producing cells.

25 October 2022 in La Revue de Médecine Interne
Verified
Journal Article
Closed access
MDM. Duval
M. Duval
MHMagalie Haissaguerre
Magalie Haissaguerre